Trial NCT03471351

View at ClinicalTrials.gov 
Org. Study IDs: RP6530+Pembrolizumab-1701

Last trial update was posted on 2019-12-27

MeSH Interventions

Pembrolizumab Tenalisib

MeSH Conditions

Hodgkin Disease

Other Conditions

Classical Hodgkin Lymphoma

Stopping Reasons

At this point, the current study in HL does not fit into clinical development and regulatory strategy.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID